Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07864181 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

TheraCal PT vs. Formocresol in Primary Molar Pulpotomies

StatusCompleted
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This prospective, randomized, parallel-group clinical trial evaluated the 12-month clinical and radiographic success rates of TheraCal PT versus formocresol in primary molar vital pulpotomies among 50 children aged 5 to 8 years. At the conclusion of the follow-up period, both materials demonstrated a 100% clinical success rate, while radiographic success rates were 92% for the formocresol group and 80% for the TheraCal PT group, showing no statistically significant differences between the two treatments.
Trial Details
NCT Number NCT07864181
Lead Sponsor Hama University
Conditions
(from sponsor)		 Reversible Pulpitis
Related terms Dental Caries, Dental Pulp Exposure
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov